Search results
Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society...
KTLA-TV Los Angeles· 7 hours agoBiosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced late-breaking results from the pivotal phase of the admIRE pivotal clinical ...
QuickLogic Reports First Quarter Fiscal 2024 Results, On Track for Revenue Growth of 30% and...
NBC 10 - FOX 14 Monroe· 4 days agoQuickLogic Corporation (NASDAQ: QUIK) ("QuickLogic" or the "Company"), a developer of embedded FPGA (eFPGA) IP, ruggedized FPGAs and Endpoint AI solutions, today announced ...